ArticleFrontiers in oncology2022

Case Report: Short-Term Response to First-Line Crizotinib Monotherapy in a Metastatic Lung Adenocarcinoma Patient Harboring a Novel

Shuli Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.